Literature DB >> 12113267

Development and validation of QoL5 for clinical databases. A short, global and generic questionnaire based on an integrated theory of the quality of life.

Jes S Lindholt1, Søren Ventegodt, Eskild W Henneberg.   

Abstract

OBJECTIVE: To develop and validate a short, global, and generic quality of life (QoL) questionnaire for clinical databases. The construct validity and item weighting of existing questionnaires are increasingly questioned.
DESIGN: Cross-sectional population study. SUBJECT: 2460 Danes aged 18-88 years, randomly selected through the Danish Central Person Registry.
INTERVENTIONS: Ten questions covering the spectrum of the integrative theory of QoL together with the Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), and self-estimated QoL questionnaire were sent by mail. A test-retest study of 50 people was conducted after one month. MAIN OUTCOME MEASURES: Construct and criterion validity, reliability, and sensitivity.
RESULTS: QoL5 correlations with SIP, NHP, Self-estimated QoL were 0.37, 0.52, and 0.76, respectively, and increased among those who were unwell. Cronbach's alpha was 0.69. All correlations in Siegel's test were over 0.6, and the test-retest correlation was 0.82. Only 12 respondents in each group will be needed to detect a difference of 10% in the QoL score between two groups.
CONCLUSIONS: QoL5 is a valid global and generic QoL measurement. Despite the use of only five questions, internal consistency and sensitivity were acceptable. So a relevant and practical outcome measurement is available for clinical databases.

Entities:  

Mesh:

Year:  2002        PMID: 12113267     DOI: 10.1080/11024150252884331

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  20 in total

1.  A comparison of four different HRQoL generic questionnaire in five different patient groups.

Authors:  Lale Akbulut Aktekin; Filiz Eser; Simten Malhan; Ergun Öksüz; Dilek Keskin; Hatice Bodur
Journal:  Rheumatol Int       Date:  2009-11       Impact factor: 2.631

2.  Smoking among inpatients in treatment for substance use disorders: prevalence and effect on mental health and quality of life.

Authors:  Lars Lien; Ingeborg Bolstad; Jørgen G Bramness
Journal:  BMC Psychiatry       Date:  2021-05-11       Impact factor: 3.630

3.  Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial.

Authors:  Michael Von Korff; Wayne J Katon; Elizabeth H B Lin; Paul Ciechanowski; Do Peterson; Evette J Ludman; Bessie Young; Carolyn M Rutter
Journal:  BMJ       Date:  2011-11-10

4.  The effectiveness of a brief mind-body intervention for treating depression in community health center patients.

Authors:  Kathleen M Miller; Emma Chad-Friedman; Vivian Haime; Darshan H Mehta; Veronique Lepoutre; Dinah Gilburd; Donna Peltier-Saxe; Cally Lilley; Herbert Benson; Gregory L Fricchione; John W Denninger; Albert Yeung
Journal:  Glob Adv Health Med       Date:  2015-03

5.  Quality of life in patients with visual impairment in Ibadan: a clinical study in primary care.

Authors:  Kehinde Adigun; Tunji S Oluleye; Modupe Ma Ladipo; Samuel Anu Olowookere
Journal:  J Multidiscip Healthc       Date:  2014-04-17

6.  Quality of life improved following in-patient substance use disorder treatment.

Authors:  Adrian R Pasareanu; Anne Opsal; John-Kåre Vederhus; Øistein Kristensen; Thomas Clausen
Journal:  Health Qual Life Outcomes       Date:  2015-03-14       Impact factor: 3.186

7.  Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders.

Authors:  Bente Birkeland; Bente Weimand; Torleif Ruud; Darryl Maybery; John-Kåre Vederhus
Journal:  Addict Sci Clin Pract       Date:  2021-06-30

8.  Validating the generic quality of life tool "QOL10" in a substance use disorder treatment cohort exposes a unique social construct.

Authors:  Ashley E Muller; Svetlana Skurtveit; Thomas Clausen
Journal:  BMC Med Res Methodol       Date:  2016-05-23       Impact factor: 4.615

9.  Perceived quality of life, 6 months after detoxification: Is abstinence a modifying factor?

Authors:  John-Kåre Vederhus; Bente Birkeland; Thomas Clausen
Journal:  Qual Life Res       Date:  2016-03-19       Impact factor: 4.147

10.  Quality of Life in Patients with Substance Use Disorders Admitted to Detoxification Compared with Those Admitted to Hospitals for Medical Disorders: Follow-Up Results.

Authors:  John-Kåre Vederhus; Are Hugo Pripp; Thomas Clausen
Journal:  Subst Abuse       Date:  2016-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.